Works matching IS 20445385 AND DT 2022 AND VI 12 AND IP 8

Results: 9
    1
    2
    3

    The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00715-4
    By:
    • Meier, Ruth;
    • Greve, Gabriele;
    • Zimmer, Dennis;
    • Bresser, Helena;
    • Berberich, Bettina;
    • Langova, Ralitsa;
    • Stomper, Julia;
    • Rubarth, Anne;
    • Feuerbach, Lars;
    • Lipka, Daniel B.;
    • Hey, Joschka;
    • Grüning, Björn;
    • Brors, Benedikt;
    • Duyster, Justus;
    • Plass, Christoph;
    • Becker, Heiko;
    • Lübbert, Michael
    Publication type:
    Article
    4

    Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00714-5
    By:
    • Havasi, Andrea;
    • Heybeli, Cihan;
    • Leung, Nelson;
    • Angel-Korman, Avital;
    • Sanchorawala, Vaishali;
    • Cohen, Oliver;
    • Wechalekar, Ashutosh;
    • Bridoux, Frank;
    • Jaffer, Insara;
    • Gutgarts, Victoria;
    • Hassoun, Hani;
    • Levinson, Maya;
    • Rosenbaum, Cara;
    • Milani, Paolo;
    • Palladini, Giovanni;
    • Merlini, Giampaolo;
    • Hegenbart, Ute;
    • Schönland, Stefan;
    • Veelken, Kaya;
    • Pogrebinsky, Alexander
    Publication type:
    Article
    5
    6

    Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00712-7
    By:
    • Vergez, François;
    • Largeaud, Laetitia;
    • Bertoli, Sarah;
    • Nicolau, Marie-Laure;
    • Rieu, Jean-Baptiste;
    • Vergnolle, Inès;
    • Saland, Estelle;
    • Sarry, Audrey;
    • Tavitian, Suzanne;
    • Huguet, Françoise;
    • Picard, Muriel;
    • Vial, Jean-Philippe;
    • Lechevalier, Nicolas;
    • Bidet, Audrey;
    • Dumas, Pierre-Yves;
    • Pigneux, Arnaud;
    • Luquet, Isabelle;
    • Mansat-De Mas, Véronique;
    • Delabesse, Eric;
    • Carroll, Martin
    Publication type:
    Article
    7

    Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00711-8
    By:
    • Frechette, Kelsey M.;
    • Lester, Scott C.;
    • Taparra, Kekoa;
    • Breen, William G.;
    • Martenson, James A.;
    • Hoppe, Bradford S.;
    • Peterson, Jennifer L.;
    • Rule, William G.;
    • Stafford, Scott L.;
    • Stish, Bradley J.;
    • Habermann, Thomas M.;
    • Young, Jason R.;
    • Harmsen, William S.;
    • Laack, Nadia N.
    Publication type:
    Article
    8

    Venetoclax ex vivo functional profiling predicts improved progression-free survival.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00710-9
    By:
    • Gupta, Vikas A.;
    • Matulis, Shannon M.;
    • Barwick, Benjamin G.;
    • Bog, R. Devin;
    • Shebelut, Conrad W.;
    • Shanmugam, Mala;
    • Neri, Paola;
    • Bahlis, Nizar J.;
    • Dhodapkar, Madhav V.;
    • Heffner, Leonard T.;
    • Hofmeister, Craig C.;
    • Joseph, Nisha S.;
    • Lonial, Sagar;
    • Kaufman, Jonathan L.;
    • Jaye, David L.;
    • Nooka, Ajay K.;
    • Boise, Lawrence H.
    Publication type:
    Article
    9